Author Affiliations: Unit é de G én étique M édicale et Laboratoire Associ é Institut National de la Sant é et de la R écherche M édicale Unit é Mixte de R écherche en Sant é 910, Universit é Saint Joseph (Drs Maalouf, Chouery, and A. M égarban é), and Department of Dermatology, Saint George Hospital (Drs H. M égarban é and Nasr), Beirut, Lebanon; Laboratoire de G én étique Mol éculaire, H ôpital d ’Enfants de la Timone, Marseille (Dr Badens and Ms Lacoste), and Institut J ér ôme Lejeune, Paris (Dr A. M égarban é), France; and Department of Human Genetics, University of Marburg, Marburg, Germany (Dr Grzeschik).
Background Focal dermal hypoplasia (also known as Goltz syndrome) is an X-linked dominant syndrome characterized by patchy hypoplastic skin with soft-tissue, skeletal, dental, and ocular defects that are secondary to mutations in the PORCN gene. To our knowledge, only 5 cases of focal dermal hypoplasia with unilateral presentation have been reported, and molecular studies were not performed in any of the cases.
Observations A 17-year-old girl was seen with features of almost unilateral focal dermal hypoplasia. These included left cleft hand, dental dysplasia, left mammary hypoplasia, deviation of the sacral line, raspberrylike papillomas in the perianal region, syndactyly of the second and third digits of the left foot, and linear streaks of dermal hypoplasia and pigmented lesions on her left hemibody.
Conclusions Mutation analysis of PORCN revealed a novel heterozygous mutation in exon 10, c.854-855insACCTGAC; [p.T285fsX316], resulting in a premature stop signal. Analysis of the X-chromosome inactivation status was performed on blood and skin DNA samples, showing random inactivation in blood and unaffected skin and skewed inactivation in affected skin, highlighting the role of X-chromosome inactivation in X-linked disease expression.
Focal dermal hypoplasia (also known as Goltz syndrome) is an X-linked dominant genodermatosis characterized by developmental defects in ectodermal and mesodermal structures, leading primarily to patchy hypoplastic skin and pigmentary changes, often following Blaschko lines, with skeletal, ocular, and dental malformations.1,2 It is secondary to mutations in the PORCN gene (OMIM 300651) located on chromosome Xp11.23.3,4PORCN encodes an O-acyltransferase involved in the palmitoylation and secretion of Wnt signaling proteins that are required for embryonic tissue development, notably for fibroblast proliferation and osteogenesis.5,6 Among more than 100 patients with focal dermal hypoplasia described in the literature, only 5 had unilateral presentation, and molecular studies were not performed in any of the cases.7- 11
In this case report, a Lebanese girl with almost unilateral focal dermal hypoplasia and a novel heterozygous mutation is described. X-chromosome inactivation status in blood and skin samples was examined to further delineate the lateralization pattern.
The consultand was born at term to a healthy gravida 6, para 5 mother. The pregnancy and labor were uneventful. At birth, multiple skin and skeletal abnormalities were noted on the left side of the body. She was first seen by us at age 17 years. Her psychomotor development was normal, and her height was 154 cm. Clinical examination revealed hypopigmented atrophic macules and hyperpigmented lesions following Blaschko lines or showing a reticulate grouping involving the left side of the chest and left extremities. A few hyperpigmented and slightly atrophic lesions were noted on the right side of the back. She had soft yellow nodules on the left hand and raspberrylike papillomas in the perianal region. She also demonstrated oligodontia, left cleft hand, left mammary hypoplasia, deviation of the sacral line, malformed and irregularly spaced teeth, and syndactyly of the second and third toes of the left foot (Figure). There were no ocular signs or internal organ anomalies. Chromosomal analysis revealed a normal 46,XX karyotype.
Figure. Present case. A, Atrophic lesions and pigmentary changes on the left side of the back. B, Abnormally shaped and irregularly spaced teeth. C, Left cleft hand. D, Syndactyly of the second and third digits of the left foot.
Gene sequence analysis was performed on the PORCN gene. After informed consent was obtained, genomic DNA was extracted from peripheral leucocytes, and the 14 coding exons of PORCN were amplified. A novel heterozygous mutation was detected in exon 10, c.854-855insACCTGAC; [p.T285fsX316], resulting in a premature stop signal. This mutation was confirmed by single-strand confirmation polymorphism analysis and was not found in 100 unrelated control subjects.
Analysis of the X-chromosome inactivation status pattern using the human androgen receptor methylation assay was performed on blood and skin DNA samples.12 The X-chromosome inactivation pattern in DNA isolated from blood identified random inactivation, with a ratio of 30:70. Using a kit (QIAGEN, Studio City, California), DNA was then extracted from small skin samples of affected and unaffected sites. The DNA from apparently healthy skin of the right arm showed random inactivation (45:55 ratio). On the affected (left) side, there was skewed inactivation in DNA extracted from an atrophic hyperpigmented lesion of the left arm (87:13 ratio) and borderline random inactivation in DNA extracted from apparently healthy skin of the left arm (75:25 ratio).
A female patient having focal dermal hypoplasia with classic features of the disease also had mammary hypoplasia and cleft hand, which are rare.3,13 Her skin lesions were predominantly on the left side of the body. Only 5 cases of focal dermal hypoplasia with unilateral presentation have been previously reported, 1 boy and 4 girls (Table). There was no preferential left-sided or right-sided unilateral involvement. Four patients had asymmetric skeletal defects, and 3 girls had ocular anomalies. Molecular studies were not performed in any of these cases. In the present case, a novel heterozygous frameshift mutation in exon 10 of PORCN, resulting in a premature stop signal, was encountered. Six cases with exon 10 mutations have been reported.3,14- 17 Clinical comparison showed no genotype-phenotype correlation, which can be secondary to lyonization or postzygotic mosaicism or various environmental and epigenetic factors.3,4
To better understand the lateralization pattern seen in our patient, we performed X-chromosome inactivation studies on blood and skin DNA samples from both sides of her body. X-chromosome inactivation has been previously studied using DNA derived from peripheral leukocytes of patients with focal dermal hypoplasia.3,4,14- 20 Patients with de novo point mutations usually demonstrated random inactivation, whereas patients with familial focal dermal hypoplasia and all patients with microdeletions encompassing PORCN and neighboring genes showed extreme skewing, possibly to allow the viability of individuals with such deleterious mutations. As expected in the present case, a random pattern of X-chromosome inactivation was identified in blood and in skin on the right side of the body. However, on the left side, there was consistent preferential bias to inactivate 1 of the 2 alleles, and skewed X-chromosome inactivation was found in DNA extracted from an atrophic skin lesion. It is probable that the bias observed on the affected side is due to an expansion of cells carrying the active mutated X, leading to the left-sided distribution of the disease features. Another explanation for this lateralization pattern is somatic mosaicism, resulting from an early somatic mutation in the precursor cells on the left side of the body. In this case, X-chromosome inactivation would be superimposed on the mosaicism and cause Blaschko lines.
In conclusion, more case reports and further molecular studies of patients with unilateral focal dermal hypoplasia are warranted. Examination of differential X-chromosome expression in involved tissues will better correlate the X-chromosome inactivation pattern and the observed phenotype.
Correspondence: Andr é M égarban é, MD, PhD, Unit é de G én étique M édicale, Universit é Saint Joseph, 42 Rue de Grenelle, 75007 Paris, France (email@example.com).
Accepted for Publication: August 24, 2011.
Author Contributions: All authors had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: H. M égarban é and A. M égarban é. Acquisition of data: Maalouf, H. M égarban é, and Nasr. Analysis and interpretation of data: Maalouf, H. M égarban é, Badens, and Grzeschik. Drafting of the manuscript: Maalouf and A. M égarban é. Critical revision of the manuscript for important intellectual content: Badens, Grzeschik, and A. M égarban é. Administrative, technical, or material support: Chouery, Badens, and Lacoste. Study supervision: A. M égarban é.
Financial Disclosure: None reported.
Funding/Support: This study was supported by Universit é Saint Joseph.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Dermatology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 4
Customize your page view by dragging & repositioning the boxes below.
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.